|
1
|
Wu M, Rementer C and Giachelli CM:
Vascular calcification: An update on mechanisms and challenges in
treatment. Calcif Tissue Int. 93:365–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
London GM: Mechanisms of arterial
calcifications and consequences for cardiovascular function. Kidney
Int Suppl (2011). 3:442–445. 2013. View Article : Google Scholar
|
|
3
|
Evrard S, Delanaye P, Kamel S, Cristol JP
and Cavalier E; SFBC/SN joined working group on vascular
calcifications: Vascular calcification: From pathophysiology to
biomarkers. Clin Chim Acta. 438:401–414. 2015. View Article : Google Scholar
|
|
4
|
McCarty MF and DiNicolantonio JJ: The
molecular biology and pathophysiology of vascular calcification.
Postgrad Med. 126:54–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El Hadj Othmane T, Speer G, Fekete B,
Szabó T, Egresits J, Fodor E, Kiss I, Nemcsik J, Szabó A, Németh Z,
et al: Osteoprotegerin: Regulator, protector and marker. Orv Hetil.
149:1971–1980. 2008.In Hungarian. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohamadpour AH, Abdolrahmani L, Mirzaei H,
Sahebkar A, Moohebati M, Ghorbani M, Ferns GA and Ghayour-Mobarhan
M: Serum osteopontin concentrations in relation to coronary artery
disease. Arch Med Res. 46:112–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murphy MB, Moncivais K and Caplan AI:
Mesenchymal stem cells: Environmentally responsive therapeutics for
regenerative medicine. Exp Mol Med. 45:e542013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yagi H, Soto-Gutierrez A, Parekkadan B,
Kitagawa Y, Tompkins RG, Kobayashi N and Yarmush ML: Mesenchymal
stem cells: Mechanisms of immunomodulation and homing. Cell
Transplant. 19:667–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YK and Chen CS: Cell adhesion and
mechanical stimulation in the regulation of mesenchymal stem cell
differentiation. J Cell Mol Med. 17:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chou SH, Lin SZ, Kuo WW, Pai P, Lin JY,
Lai CH, Kuo CH, Lin KH, Tsai FJ and Huang CY: Mesenchymal stem cell
insights: Prospects in cardiovascular therapy. Cell Transplant.
23:513–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xin H, Xin F, Zhou S and Guan S: The
Wnt5a/Ror2 pathway is associated with determination of the
differentiation fate of bone marrow mesenchymal stem cells in
vascular calcification. Int J Mol Med. 31:583–588. 2013.PubMed/NCBI
|
|
12
|
Watt SM, Gullo F, van der Garde M,
Markeson D, Camicia R, Khoo CP and Zwaginga JJ: The angiogenic
properties of mesenchymal stem/stromal cells and their therapeutic
potential. Br Med Bull. 108:25–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L and Xu Q: Stem/Progenitor cells in
vascular regeneration. Arterioscler Thromb Vasc Biol. 34:1114–1119.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim SW, Houge M, Brown M, Davis ME and
Yoon YS: Cultured human bone marrow-derived CD31(+)
cells are effective for cardiac and vascular repair through
enhanced angiogenic, adhesion, and anti-inflammatory effects. J Am
Coll Cardiol. 64:1681–1694. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marinou K, Christodoulides C, Antoniades C
and Koutsilieris M: Wnt signaling in cardiovascular physiology.
Trends Endocrinol Metab. 23:628–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mill C and George SJ: Wnt signalling in
smooth muscle cells and its role in cardiovascular disorders.
Cardiovasc Res. 95:233–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Bodine PV and Billiard J: Ror2, a
novel modulator of osteogenesis. J Musculoskelet Neuronal Interact.
7:323–324. 2007.PubMed/NCBI
|
|
18
|
Billiard J, Way DS, Seestaller-Wehr LM,
Moran RA, Mangine A and Bodine PV: The orphan receptor tyrosine
kinase Ror2 modulates canonical Wnt signaling in osteoblastic
cells. Mol Endocrinol. 19:90–101. 2005. View Article : Google Scholar
|
|
19
|
van Amerongen R, Fuerer C, Mizutani M and
Nusse R: Wnt5a can both activate and repress Wnt/β-catenin
signaling during mouse embryonic development. Dev Biol.
369:101–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maeda K, Kobayashi Y, Udagawa N, Uehara S,
Ishihara A, Mizoguchi T, Kikuchi Y, Takada I, Kato S, Kani S, et
al: Wnt5a-Ror2 signaling between osteoblast-lineage cells and
osteoclast precursors enhances osteoclastogenesis. Nat Med.
18:405–412. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Zhang Y and Qi G: Evaluation of
isolation methods and culture conditions for rat bone marrow
mesenchymal stem cells. Cytotechnology. 65:323–334. 2013.
View Article : Google Scholar :
|
|
22
|
Yan J, Tie G, Xu TY, Cecchini K and
Messina LM: Mesenchymal stem cells as a treatment for peripheral
arterial disease: Current status and potential impact of type II
diabetes on their therapeutic efficacy. Stem Cell Rev. 9:360–372.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee
IH, Lin WS, Wu CH, Lin WY and Cheng SM: Mesenchymal stem cells from
human umbilical cord express preferentially secreted factors
related to neuroprotection, neurogenesis, and angiogenesis. PLoS
One. 8:e726042013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
King A, Balaji S, Keswani SG and
Crombleholme TM: The role of stem cells in wound angiogenesis. Adv
Wound Care (New Rochelle). 3:614–625. 2014. View Article : Google Scholar
|
|
25
|
Burlacu A, Grigorescu G, Rosca AM, Preda
MB and Simionescu M: Factors secreted by mesenchymal stem cells and
endothelial progenitor cells have complementary effects on
angiogenesis in vitro. Stem Cells Dev. 22:643–653. 2013. View Article : Google Scholar :
|
|
26
|
Pal SN and Golledge J: Osteo-progenitors
in vascular calcification: A circulating cell theory. J Atheroscler
Thromb. 18:551–559. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kramann R, Kunter U, Brandenburg VM,
Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J and
Schneider RK: Osteogenesis of heterotopically transplanted
mesenchymal stromal cells in rat models of chronic kidney disease.
J Bone Miner Res. 28:2523–2534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang W, Li C, Pang L, Shi C, Guo F, Chen
A, Cao X and Wan M: Mesenchymal stem cells recruited by active TGFβ
contribute to osteogenic vascular calcification. Stem Cells Dev.
23:1392–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montañez-Barragán A, Gómez-Barrera I,
Sanchez-Niño MD, Ucero AC, González-Espinoza L and Ortiz A:
Osteoprotegerin and kidney disease. J Nephrol. 2014.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morena M, Dupuy AM, Jaussent I, Vernhet H,
Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B and Cristol
JP: A cut-off value of plasma osteoprotegerin level may predict the
presence of coronary artery calcifications in chronic kidney
disease patients. Nephrol Dial Transplant. 24:3389–3397. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guan S, Wang Z, Xin F and Xin H: Wnt5a is
associated with the differentiation of bone marrow mesenchymal stem
cells in vascular calcification by connecting with different
receptors. Mol Med Rep. 10:1985–1991. 2014.PubMed/NCBI
|
|
32
|
Montes de Oca A, Guerrero F,
Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A, Almaden Y,
Lopez I, Aguilera-Tejero E, Gundlach K, et al: Magnesium inhibits
Wnt/β-catenin activity and reverses the osteogenic transformation
of vascular smooth muscle cells. PLoS One. 9:e895252014. View Article : Google Scholar
|
|
33
|
Bolzoni M, Donofrio G, Storti P, Guasco D,
Toscani D, Lazzaretti M, Bonomini S, Agnelli L, Capocefalo A, Dalla
Palma B, et al: Myeloma cells inhibit non-canonical wnt co-receptor
ror2 expression in human bone marrow osteoprogenitor cells: Effect
of wnt5a/ror2 pathway activation on the osteogenic differentiation
impairment induced by myeloma cells. Leukemia. 27:451–463. 2013.
View Article : Google Scholar
|
|
34
|
Huh JE, Choi JY, Shin YO, Park DS, Kang
JW, Nam D, Choi DY and Lee JD: Arginine enhances osteoblastogenesis
and inhibits adipogenesis through the regulation of Wnt and NFATc
signaling in human mesenchymal stem cells. Int J Mol Sci.
15:13010–13029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai SX, Liu AR, He HL, Chen QH, Yang Y,
Guo FM, Huang YZ, Liu L and Qiu HB: Stable genetic alterations of
β-catenin and ROR2 regulate the Wnt pathway, affect the fate of
MSCs. J Cell Physiol. 229:791–800. 2014. View Article : Google Scholar : PubMed/NCBI
|
